Institutional Ownership Adaptimmune Therapeutics PLC (ADAP)
This table provides information about the institutional ownership of Adaptimmune Therapeutics PLC (ADAP). We have compiled data on the 75 institutions that hold shares in the stock, with a total of 114 Million shares, which have been reported (via 13F filing form) to have a value of $32 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Eco R1 Capital, LLC
San Francisco, CA |
May 15, 2025 Q1 2025 |
27,404,070
shares
|
$7.67 Million
0.43% of portfolio
|
Q1 2024
New holding
|
|
Long Focus Capital Management, LLC
San Juan, PR |
May 15, 2025 Q1 2025 |
23,756,687
shares
|
$6.65 Million
0.16% of portfolio
|
Q1 2025
Added 15.92%
|
|
Two Seas Capital LP
Rye, NY |
May 15, 2025 Q1 2025 |
20,529,685
shares
|
$5.75 Million
0.15% of portfolio
|
Q1 2025
Added 38.39%
|
|
Nea Management Company, LLC
Timonium, MD |
May 14, 2025 Q1 2025 |
17,079,778
shares
|
$4.78 Million
0.32% of portfolio
|
Q2 2023
Reduced -0.0%
|
|
Mpm Asset Management LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
5,335,715
shares
|
$1.49 Million
1.54% of portfolio
|
Q1 2025
Reduced 3.96%
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
4,894,344
shares
|
$1.37 Million
0.18% of portfolio
|
Q1 2025
Reduced 3.96%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
2,715,947
shares
|
$760,465
0.0% of portfolio
|
Q1 2025
Added 105.0%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
2,483,468
shares
|
$695,371
0.03% of portfolio
|
Q4 2024
Added 2.39%
|
|
Acadian Asset Management LLC
Boston, MA |
May 21, 2025 Q1 2025 |
2,218,215
shares
|
$621,100
0.0% of portfolio
|
Q1 2025
Added 334.76%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
1,813,860
shares
|
$507,880
0.0% of portfolio
|
Q1 2025
Reduced 28.21%
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
1,147,013
shares
|
$321,163
0.0% of portfolio
|
Q1 2025
Reduced 59.93%
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
1,012,740
shares
|
$283,567
0.0% of portfolio
|
Q1 2025
Added 614.49%
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
882,331
shares
|
$247,052
0.0% of portfolio
|
Q1 2025
Reduced 3.77%
|
|
Rathbones Group PLC
Liverpool, X0 |
May 13, 2025 Q1 2025 |
432,818
shares
|
$121,189
0.0% of portfolio
|
Q4 2021
Reduced 0.02%
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
421,292
shares
|
$117,961
0.0% of portfolio
|
Q1 2025
Added 5.3%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
May 15, 2025 Q1 2025 |
206,732
shares
|
$57,884
0.0% of portfolio
|
Q1 2025
Added 192.26%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
193,757
shares
|
$54,251
0.0% of portfolio
|
Q2 2024
Reduced 33.12%
|
|
Key Client Fiduciary Advisors, LLC
|
Jul 09, 2025 Q2 2025 |
175,555
shares
|
$49,155
0.02% of portfolio
|
Q2 2025
Added 16.92%
|
|
Clear Harbor Asset Management, LLC
|
Jul 14, 2025 Q2 2025 |
145,400
shares
|
$40,712
0.0% of portfolio
|
Q2 2025
Reduced 39.6%
|
|
Two Sigma Investments, LP
New York, NY |
May 15, 2025 Q1 2025 |
135,947
shares
|
$38,065
0.0% of portfolio
|
Q1 2025
Added 78.06%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
109,066
shares
|
$30,538
0.0% of portfolio
|
Q1 2025
Reduced 21.98%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
94,283
shares
|
$26,399
0.0% of portfolio
|
Q1 2025
Added 218.97%
|
|
Act Capital Management, LLC
Wayne, PA |
Nov 03, 2022 Q3 2022 |
90,000
shares
|
$25,200
0.13% of portfolio
|
Q3 2021
New holding
|
|
Graham Capital Management, L.P.
Rowayton, CT |
May 15, 2025 Q1 2025 |
87,274
shares
|
$24,436
0.0% of portfolio
|
Q1 2025
Added 134.64%
|
|
Captrust Financial Advisors
Raleigh, NC |
May 14, 2025 Q1 2025 |
80,609
shares
|
$22,570
0.0% of portfolio
|
Q1 2025
Reduced 1.25%
|